- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 419/14 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Patent holdings for IPC class C07D 419/14
Total number of patents in this class: 163
10-year publication summary
|
9
|
10
|
10
|
17
|
16
|
5
|
18
|
12
|
20
|
9
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Astex Therapeutics Limited | 207 |
7 |
| Merck Patent GmbH | 5731 |
6 |
| Amgen Inc. | 4431 |
6 |
| Bayer Cropscience AG | 1838 |
5 |
| Rigel Pharmaceuticals, Inc. | 505 |
5 |
| BASF SE | 21318 |
4 |
| Celgene Corporation | 1413 |
4 |
| Daiichi Sankyo Company, Limited | 1890 |
4 |
| Kyoto Pharmaceutical Industries, Ltd. | 21 |
4 |
| Janssen Pharmaceutica N.V. | 3160 |
3 |
| Bayer AG | 3504 |
3 |
| Glaxosmithkline Intellectual Property Development Limited | 779 |
3 |
| Dana-Farber Cancer Institute, Inc. | 2666 |
3 |
| Duk San Neolux Co., Ltd. | 703 |
3 |
| Jacobio Pharmaceuticals Co., Ltd. | 104 |
3 |
| Gluetacs Therapeutics (Shanghai) Co., Ltd. | 41 |
3 |
| Novartis AG | 10224 |
2 |
| LG Chem, Ltd. | 17937 |
2 |
| AstraZeneca AB | 2820 |
2 |
| Millennium Pharmaceuticals, Inc. | 426 |
2 |
| Other owners | 89 |